Related Experiment Video
Updated: Aug 1, 2026
08:27
A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
MeCP2 dysfunction in Rett syndrome and related disorders.
1Baylor College of Medicine, One Baylor Plaza, T807, Mail Stop 225, Houston, TX 77030, USA.
Current Opinion in Genetics & Development
|May 2, 2006
Summary
Rett syndrome, a neurodevelopmental disorder, stems from mutations in the methyl-CpG-binding protein 2 (MeCP2) gene. Understanding MeCP2
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Rett syndrome is a significant neurodevelopmental disorder linked to the X-linked methyl-CpG-binding protein 2 (MeCP2) gene.
- Mutations in MECP2 are associated with diverse conditions, including autism, mental retardation, and neonatal encephalopathy.
- MeCP2 is a transcriptional repressor crucial for regulating gene expression and chromatin structure.
Purpose of the Study:
- To elucidate the complex molecular pathogenesis of Rett syndrome and related disorders.
- To identify genes misregulated due to MeCP2 dysfunction.
- To demonstrate the role of these genes in neuronal dysfunction and disease.
Main Methods:
- Analysis of gene expression changes in Rett patients and mouse models.
- Investigation of MeCP2's role in transcriptional repression and chromatin modification.
- Assessment of RNA splicing abnormalities associated with MeCP2 dysfunction.
Main Results:
- Subtle gene expression alterations are observed in Rett syndrome.
- MeCP2 dysfunction impacts RNA splicing, indicating a complex disease mechanism.
- Identification of specific misregulated genes is crucial for understanding pathogenesis.
Conclusions:
- MeCP2 plays a critical role in neuronal development and function.
- Understanding MeCP2-regulated genes is essential for developing therapeutic strategies for Rett syndrome.
- Further research is needed to fully unravel the molecular basis of MeCP2-associated disorders.
Related Concept Videos
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:19Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.